Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Deepak Kotiya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA; The Research Center for Healthy Metabolism, Un…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Brain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Islet amyloid polypeptide (amylin) secreted from the pancreas crosses from the blood to the brain parenchyma and forms cerebral mixed amylin-β amyloid (Aβ) plaques in persons with Alzheimer's disease (AD). Cerebral amylin-Aβ plaques are found in both sporadic and early-onset familial AD; however, the role of amylin-Aβ co-aggregation in potential mechanisms underlying this association remains unknown, in part due to lack of assays for detection of these complexes. Here, we report the development of an ELISA to detect amylin-Aβ hetero-oligomers in brain tissue and blood. The amylin-Aβ ELISA relies on a monoclonal anti-Aβ mid-domain antibody (detection) and a polyclonal anti-amylin antibody (capture) designed to recognize an epitope that is distinct from the high affinity amylin-Aβ binding sites. The utility of this assay is supported by the analysis of molecular amylin-Aβ codeposition in postmortem brain tissue obtained from persons with and without AD pathology. By using transgenic AD-model rats, we show that this new assay can detect circulating amylin-Aβ hetero-oligomers in the blood and is sensitive to their dissociation to monomers. This is important because therapeutic strategies to block amylin-Aβ co-aggregation could reduce or delay the development and progression of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA; The Research Center for Healthy Metabolism, University of Kentucky, Lexington, Kentucky, USA.
- Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA; Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA; The Research Center for Healthy Metabolism, University of Kentucky, Lexington, Kentucky, USA; Department of Neurolog…
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Kotiya, D., Leibold, N., Verma, N., Jicha, G. A., Goldstein, L. B., & Despa, F. (2023). Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104682
Vancouver
Kotiya D, Leibold N, Verma N, Jicha GA, Goldstein LB, Despa F. Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104682
BibTeX
@article{Kotiya2023,
author = {Kotiya, Deepak and Leibold, Noah and Verma, Nirmal and Jicha, Gregory A and Goldstein, Larry B and Despa, Florin},
title = {Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104682}
}
EUVIMED